Browsing by Author "Martin, Miguel"
Now showing items 1-3 of 3
-
A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer
Pascual, Tomás; Martin, Miguel; Fernández-Martínez, Aranzazu; Alba, Emilio; Rodríguez-Lescure, Álvaro; Cortés Castan, Javier; Paré, Laia (Frontiers Media, 2019-04-26) -
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
Johnston, Stephen RD; Harbeck, Nadia; Hegg, Roberto; Toi, Masakazu; Martin, Miguel; Shao, Zhi Min; Cortés Castan, Javier (American Society of Clinical Oncology, 2020-12-01) -
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies
Schoffski, Patrick; Tan, Daniel S. W.; Martin, Miguel; Ochoa de Olza Amat, Maria; Sarantopoulos, John; Carvajal, Richard (BMJ, 2022-02)